{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:56:49Z","timestamp":1793224609206,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DP2DK111910"],"award-info":[{"award-number":["DP2DK111910"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK123293"],"award-info":[{"award-number":["R01DK123293"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1410853"],"award-info":[{"award-number":["1410853"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1809229"],"award-info":[{"award-number":["1809229"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Nanotechnol."],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1038\/s41565-020-0693-6","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T12:03:55Z","timestamp":1591013035000},"page":"605-614","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":288,"title":["Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0168-657X","authenticated-orcid":false,"given":"Xiangfei","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6866-2762","authenticated-orcid":false,"given":"Ershuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8601-669X","authenticated-orcid":false,"given":"Hui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0114-2249","authenticated-orcid":false,"given":"Zhiqiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,1]]},"reference":[{"key":"693_CR1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v24.i1.30","volume":"24","author":"V Sinha","year":"2007","unstructured":"Sinha, V. et al. Oral colon-specific drug delivery of protein and peptide drugs. Crit. Rev. Ther. Drug Carrier Syst. 24, 63\u201392 (2007).","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"693_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.08.013","volume":"116","author":"A des Rieux","year":"2006","unstructured":"des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J. & Preat, V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J. Control. Release 116, 1\u201327 (2006).","journal-title":"J. Control. Release"},{"key":"693_CR3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jsps.2014.06.004","volume":"24","author":"A Muheem","year":"2016","unstructured":"Muheem, A. et al. A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives. Saudi Pharm. J. 24, 413\u2013428 (2016).","journal-title":"Saudi Pharm. J."},{"key":"693_CR4","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1016\/j.biomaterials.2006.06.011","volume":"27","author":"L Serra","year":"2006","unstructured":"Serra, L., Domenech, J. & Peppas, N. A. Drug transport mechanisms and release kinetics from molecularly designed poly(acrylic acid-g-ethylene glycol) hydrogels. Biomaterials 27, 5440\u20135451 (2006).","journal-title":"Biomaterials"},{"key":"693_CR5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2015.02.055","volume":"484","author":"F Yu","year":"2015","unstructured":"Yu, F. et al. Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin. Int. J. Pharm. 484, 181\u2013191 (2015).","journal-title":"Int. J. Pharm."},{"key":"693_CR6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v23.i2.20","volume":"23","author":"G Mustata","year":"2006","unstructured":"Mustata, G. & Dinh, S. M. Approaches to oral drug delivery for challenging molecules. Crit. Rev. Ther. Drug Carrier Syst. 23, 111\u2013135 (2006).","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"693_CR7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrd1067","volume":"2","author":"M Goldberg","year":"2003","unstructured":"Goldberg, M. & Gomez-Orellana, I. Challenges for the oral delivery of macromolecules. Nat. Rev. Drug. Discov. 2, 289\u2013295 (2003).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"693_CR8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","volume":"64","author":"LM Ensign","year":"2012","unstructured":"Ensign, L. M., Cone, R. & Hanes, J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv. Drug Deliver. Rev. 64, 557\u2013570 (2012).","journal-title":"Adv. Drug Deliver. Rev."},{"key":"693_CR9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.addr.2008.09.006","volume":"61","author":"Y Cu","year":"2009","unstructured":"Cu, Y. & Saltzman, W. M. Mathematical modeling of molecular diffusion through mucus. Adv. Drug. Deliver. Rev. 61, 101\u2013114 (2009).","journal-title":"Adv. Drug. Deliver. Rev."},{"key":"693_CR10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0006-3495(94)80802-1","volume":"66","author":"WM Saltzman","year":"1994","unstructured":"Saltzman, W. M., Radomsky, M. L., Whaley, K. J. & Cone, R. A. Antibody diffusion in human cervical-mucus. Biophys. J. 66, 508\u2013515 (1994).","journal-title":"Biophys. J."},{"key":"693_CR11","first-page":"27","volume":"1","author":"MA Chilvers","year":"2000","unstructured":"Chilvers, M. A. & O\u2019Callaghan, C. Local mucociliary defence mechanisms. Paediatr. Respir. Rev. 1, 27\u201334 (2000).","journal-title":"Paediatr. Respir. Rev."},{"key":"693_CR12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI0215217","volume":"109","author":"MR Knowles","year":"2002","unstructured":"Knowles, M. R. & Boucher, R. C. Mucus clearance as a primary innate defense mechanism for mammalian airways. J. Clin. Invest. 109, 571\u2013577 (2002).","journal-title":"J. Clin. Invest."},{"key":"693_CR13","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1172\/JCI26705","volume":"117","author":"JL McAuley","year":"2007","unstructured":"McAuley, J. L. et al. MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J. Clin. Invest. 117, 2313\u20132324 (2007).","journal-title":"J. Clin. Invest."},{"key":"693_CR14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","volume":"61","author":"R Cone","year":"2009","unstructured":"Cone, R. Barrier properties of mucus. Adv Drug Deliver. Rev. 61, 75\u201385 (2009).","journal-title":"Adv Drug Deliver. Rev."},{"key":"693_CR15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","volume":"61","author":"SK Lai","year":"2009","unstructured":"Lai, S. K., Wang, Y. & Hanes, J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv. Drug Deliver. Rev. 61, 158\u2013171 (2009).","journal-title":"Adv. Drug Deliver. Rev."},{"key":"693_CR16","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/adma.201201800","volume":"24","author":"LM Ensign","year":"2012","unstructured":"Ensign, L. M., Schneider, C., Suk, J. S., Cone, R. & Hanes, J. Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery. Adv. Mater. 24, 3887\u20133894 (2012).","journal-title":"Adv. Mater."},{"key":"693_CR17","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","volume":"104","author":"SK Lai","year":"2007","unstructured":"Lai, S. K. et al. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc. Natl Acad. Sci. USA 104, 1482\u20131487 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"693_CR18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2014.10.026","volume":"197","author":"K Maisel","year":"2015","unstructured":"Maisel, K., Ensign, L. M., Reddy, M., Cone, R. & Hanes, J. Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse. J. Control. Release 197, 48\u201357 (2015).","journal-title":"J. Control. Release"},{"key":"693_CR19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1021\/mp8001254","volume":"6","author":"Y Cu","year":"2009","unstructured":"Cu, Y. & Saltzman, W. M. Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus. Mol. Pharmaceut. 6, 173\u2013181 (2009).","journal-title":"Mol. Pharmaceut."},{"key":"693_CR20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1152\/physrev.1995.75.3.561","volume":"75","author":"SA Lewis","year":"1995","unstructured":"Lewis, S. A., Berg, J. R. & Kleine, T. J. Modulation of epithelial permeability by extracellular macromolecules. Physiol. Rev. 75, 561\u2013589 (1995).","journal-title":"Physiol. Rev."},{"key":"693_CR21","doi-asserted-by":"crossref","first-page":"e117682","DOI":"10.1080\/21688370.2016.1176822","volume":"4","author":"F McCartney","year":"2016","unstructured":"McCartney, F., Gleeson, J. P. & Brayden, D. J. Safety concerns over the use of intestinal permeation enhancers: a mini-review. Tissue Barriers 4, e117682 (2016).","journal-title":"Tissue Barriers"},{"key":"693_CR22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.addr.2016.06.005","volume":"106","author":"S Maher","year":"2016","unstructured":"Maher, S., Mrsny, R. J. & Brayden, D. J. Intestinal permeation enhancers for oral peptide delivery. Adv. Drug Deliver. Rev. 106, 277\u2013319 (2016).","journal-title":"Adv. Drug Deliver. Rev."},{"key":"693_CR23","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1007\/s11095-007-9488-9","volume":"25","author":"K Whitehead","year":"2008","unstructured":"Whitehead, K., Karr, N. & Mitragotri, S. Safe and effective permeation enhancers for oral drug delivery. Pharmaceut. Res. 25, 1782\u20131788 (2008).","journal-title":"Pharmaceut. Res."},{"key":"693_CR24","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.2337\/dc09-1807","volume":"33","author":"C Kapitza","year":"2010","unstructured":"Kapitza, C. et al. Oral Insulin: a comparison with subcutaneous regular human insulin in patients with type 2 diabetes. Diabetes Care 33, 1288\u20131290 (2010).","journal-title":"Diabetes Care"},{"key":"693_CR25","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1073\/pnas.1722338115","volume":"115","author":"A Banerjee","year":"2018","unstructured":"Banerjee, A. et al. Ionic liquids for oral insulin delivery. Proc. Natl Acad. Sci. USA 115, 7296\u20137301 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"693_CR26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1463-1326.2009.01150.x","volume":"12","author":"H Iyer","year":"2010","unstructured":"Iyer, H., Khedkar, A. & Verma, M. Oral insulin \u2013 a review of current status. Diabetes Obes. Metab. 12, 179\u2013185 (2010).","journal-title":"Diabetes Obes. Metab."},{"key":"693_CR27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.autrev.2015.01.009","volume":"14","author":"A Lerner","year":"2015","unstructured":"Lerner, A. & Matthias, T. Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmun. Rev. 14, 479\u2013489 (2015).","journal-title":"Autoimmun. Rev."},{"key":"693_CR28","doi-asserted-by":"crossref","first-page":"213ra167","DOI":"10.1126\/scitranslmed.3007049","volume":"5","author":"EM Pridgen","year":"2013","unstructured":"Pridgen, E. M. et al. Transepithelial transport of Fc-targeted nanoparticles by the neonatal Fc receptor for oral delivery. Sci. Transl. Med. 5, 213ra167 (2013).","journal-title":"Sci. Transl. Med."},{"key":"693_CR29","doi-asserted-by":"crossref","first-page":"8893","DOI":"10.1021\/acsnano.8b04315","volume":"12","author":"KS Kim","year":"2018","unstructured":"Kim, K. S., Suzuki, K., Cho, H., Youn, Y. S. & Bae, Y. H. Oral nanoparticles exhibit specific high-efficiency intestinal uptake and lymphatic transport. ACS Nano. 12, 8893\u20138900 (2018).","journal-title":"ACS Nano."},{"key":"693_CR30","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1021\/acs.molpharmaceut.8b00708","volume":"15","author":"KS Kim","year":"2018","unstructured":"Kim, K. S., Kwag, D. S., Hwang, H. S., Lee, E. S. & Bae, Y. H. Immense Insulin intestinal uptake and lymphatic transport using bile acid conjugated partially uncapped liposome. Mol. Pharmaceut. 15, 4756\u20134763 (2018).","journal-title":"Mol. Pharmaceut."},{"key":"693_CR31","doi-asserted-by":"crossref","first-page":"11625","DOI":"10.1021\/la302433a","volume":"28","author":"Z Cao","year":"2012","unstructured":"Cao, Z., Zhang, L. & Jiang, S. Superhydrophilic zwitterionic polymers stabilize liposomes. Langmuir 28, 11625\u201311632 (2012).","journal-title":"Langmuir"},{"key":"693_CR32","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41551-018-0234-x","volume":"2","author":"Y Lu","year":"2018","unstructured":"Lu, Y. et al. Micelles with ultralow critical micelle concentration as carriers for drug delivery. Nat. Biomed. Eng. 2, 318\u2013325 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"693_CR33","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/j.1476-5381.2011.01438.x","volume":"164","author":"DT Thwaites","year":"2011","unstructured":"Thwaites, D. T. & Anderson, C. M. H. The SLC36 family of proton-coupled amino acid transporters and their potential role in drug transport. Brit. J. Pharmacol. 164, 1802\u20131816 (2011).","journal-title":"Brit. J. Pharmacol."},{"key":"693_CR34","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ibd.21403","volume":"17","author":"SY Salim","year":"2011","unstructured":"Salim, S. Y. & Soderholm, J. D. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm. Bowel Dis. 17, 362\u2013381 (2011).","journal-title":"Inflamm. Bowel Dis."},{"key":"693_CR35","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1023\/A:1018823100761","volume":"43","author":"JD Soderholm","year":"1998","unstructured":"Soderholm, J. D. et al. Reversible increase in tight junction permeability to macromolecules in rat ileal mucosa in vitro by sodium caprate, a constituent of milk fat. Digest. Dis. Sci. 43, 1547\u20131552 (1998).","journal-title":"Digest. Dis. Sci."},{"key":"693_CR36","unstructured":"Brake, R., Vogl, A.W. & Mitchell, A.W.M. Gray\u2019s Anatomy For Students (Elsevier\/Churchill Livingstone, 2005)."},{"key":"693_CR37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1476-5381.2010.00888.x","volume":"161","author":"S Frolund","year":"2010","unstructured":"Frolund, S., Holm, R., Brodin, B. & Nielsen, C. U. The proton-coupled amino acid transporter, SLC36A1 (hPAT1), transports Gly-Gly, Gly-Sar and other Gly-Gly mimetics. Br. J. Pharmacol. 161, 589\u2013600 (2010).","journal-title":"Br. J. Pharmacol."},{"key":"693_CR38","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/clinchem\/39.5.888","volume":"39","author":"D Willems","year":"1993","unstructured":"Willems, D., Cadranel, S. & Jacobs, W. Measurement of urinary sugars by HPLC in the estimation of intestinal permeability-evaluation in pediatric clinical-practice. Clin. Chem. 39, 888\u2013890 (1993).","journal-title":"Clin. Chem."},{"key":"693_CR39","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3748\/wjg.v9.i8.1878","volume":"9","author":"XH Jiang","year":"2003","unstructured":"Jiang, X. H., Li, N. & Li, J. S. Intestinal permeability in patients after surgical trauma and effect of enteral nutrition versus parenteral nutrition. World J. Gastroentero. 9, 1878\u20131880 (2003).","journal-title":"World J. Gastroentero."},{"key":"693_CR40","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1053\/j.gastro.2004.08.017","volume":"127","author":"CMH Anderson","year":"2004","unstructured":"Anderson, C. M. H. et al. H+\/amino acid transporter 1 (PAT1) is the imino acid carrier: an intestinal nutrient\/drug transporter in human and rat. Gastroenterology 127, 1410\u20131422 (2004).","journal-title":"Gastroenterology"},{"key":"693_CR41","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1476-5381.2012.02030.x","volume":"167","author":"ML Broberg","year":"2012","unstructured":"Broberg, M. L. et al. Function and expression of the proton-coupled amino acid transporter PAT1 along the rat gastrointestinal tract: implications for intestinal absorption of gaboxadol. Brit. J. Pharmacol. 167, 654\u2013665 (2012).","journal-title":"Brit. J. Pharmacol."},{"key":"693_CR42","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0006-3495(01)75844-4","volume":"81","author":"SS Olmsted","year":"2001","unstructured":"Olmsted, S. S. et al. Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys. J. 81, 1930\u20131937 (2001).","journal-title":"Biophys. J."}],"container-title":["Nature Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41565-020-0693-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41565-020-0693-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41565-020-0693-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:59:56Z","timestamp":1684605596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41565-020-0693-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["693"],"URL":"https:\/\/doi.org\/10.1038\/s41565-020-0693-6","relation":{},"ISSN":["1748-3387","1748-3395"],"issn-type":[{"value":"1748-3387","type":"print"},{"value":"1748-3395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,1]]},"assertion":[{"value":"8 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}